nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—CYP2A6—lung cancer	0.391	1	CbGaD
Montelukast—SLCO2B1—Erlotinib—lung cancer	0.0956	0.265	CbGbCtD
Montelukast—PTGS1—Etoposide—lung cancer	0.0262	0.0728	CbGbCtD
Montelukast—CYP2C9—Gefitinib—lung cancer	0.0247	0.0685	CbGbCtD
Montelukast—CYP2C9—Teniposide—lung cancer	0.0239	0.0664	CbGbCtD
Montelukast—CYP2C8—Erlotinib—lung cancer	0.0209	0.0581	CbGbCtD
Montelukast—CYP2C8—Paclitaxel—lung cancer	0.0192	0.0532	CbGbCtD
Montelukast—CYP3A4—Topotecan—lung cancer	0.0157	0.0436	CbGbCtD
Montelukast—CYP2C8—Etoposide—lung cancer	0.0151	0.042	CbGbCtD
Montelukast—CYP3A4—Gefitinib—lung cancer	0.0144	0.0398	CbGbCtD
Montelukast—CYP3A4—Teniposide—lung cancer	0.0139	0.0386	CbGbCtD
Montelukast—CYP2C9—Paclitaxel—lung cancer	0.0134	0.0371	CbGbCtD
Montelukast—CYP3A4—Vinorelbine—lung cancer	0.0111	0.0307	CbGbCtD
Montelukast—CYP2C9—Cisplatin—lung cancer	0.0107	0.0298	CbGbCtD
Montelukast—CYP3A4—Crizotinib—lung cancer	0.0088	0.0244	CbGbCtD
Montelukast—CYP3A4—Erlotinib—lung cancer	0.00849	0.0236	CbGbCtD
Montelukast—CYP3A4—Paclitaxel—lung cancer	0.00777	0.0216	CbGbCtD
Montelukast—CYP3A4—Irinotecan—lung cancer	0.00766	0.0213	CbGbCtD
Montelukast—CYP3A4—Vinblastine—lung cancer	0.00681	0.0189	CbGbCtD
Montelukast—CYP3A4—Etoposide—lung cancer	0.00614	0.017	CbGbCtD
Montelukast—CYP3A4—Docetaxel—lung cancer	0.00562	0.0156	CbGbCtD
Montelukast—CYP3A4—Doxorubicin—lung cancer	0.00419	0.0116	CbGbCtD
Montelukast—CYSLTR1—respiratory system—lung cancer	0.00203	0.111	CbGeAlD
Montelukast—CYSLTR1—bronchus—lung cancer	0.00167	0.0911	CbGeAlD
Montelukast—SLCO2B1—mammary gland—lung cancer	0.00142	0.0774	CbGeAlD
Montelukast—ALOX5—respiratory system—lung cancer	0.00123	0.067	CbGeAlD
Montelukast—CYSLTR1—bone marrow—lung cancer	0.00119	0.0649	CbGeAlD
Montelukast—CYSLTR1—lung—lung cancer	0.00108	0.0588	CbGeAlD
Montelukast—ALOX5—bronchus—lung cancer	0.00101	0.0552	CbGeAlD
Montelukast—SLCO2B1—respiratory system—lung cancer	0.000945	0.0516	CbGeAlD
Montelukast—CYP2C8—mammary gland—lung cancer	0.000912	0.0498	CbGeAlD
Montelukast—CYP2C9—mammary gland—lung cancer	0.00081	0.0442	CbGeAlD
Montelukast—CYSLTR1—lymph node—lung cancer	0.000736	0.0402	CbGeAlD
Montelukast—ALOX5—bone marrow—lung cancer	0.00072	0.0393	CbGeAlD
Montelukast—ALOX5—lung—lung cancer	0.000652	0.0356	CbGeAlD
Montelukast—CYP2A6—lung—lung cancer	0.000575	0.0314	CbGeAlD
Montelukast—SLCO2B1—lung—lung cancer	0.000502	0.0274	CbGeAlD
Montelukast—PTGS1—respiratory system—lung cancer	0.000493	0.0269	CbGeAlD
Montelukast—ALOX5—lymph node—lung cancer	0.000446	0.0243	CbGeAlD
Montelukast—PTGS1—epithelium—lung cancer	0.000412	0.0225	CbGeAlD
Montelukast—PTGS1—trachea—lung cancer	0.000364	0.0199	CbGeAlD
Montelukast—SLCO2B1—lymph node—lung cancer	0.000343	0.0187	CbGeAlD
Montelukast—PTGS1—cardiac atrium—lung cancer	0.000342	0.0187	CbGeAlD
Montelukast—PTGS1—lung—lung cancer	0.000262	0.0143	CbGeAlD
Montelukast—PTGS1—lymph node—lung cancer	0.000179	0.00977	CbGeAlD
Montelukast—Nausea—Topotecan—lung cancer	0.000121	0.000823	CcSEcCtD
Montelukast—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000121	0.000822	CcSEcCtD
Montelukast—Fatigue—Gemcitabine—lung cancer	0.000121	0.000821	CcSEcCtD
Montelukast—Pain—Gemcitabine—lung cancer	0.00012	0.000814	CcSEcCtD
Montelukast—Nausea—Erlotinib—lung cancer	0.00012	0.000814	CcSEcCtD
Montelukast—Anaphylactic shock—Etoposide—lung cancer	0.00012	0.000813	CcSEcCtD
Montelukast—Diarrhoea—Vinorelbine—lung cancer	0.00012	0.000811	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000119	0.000809	CcSEcCtD
Montelukast—Infection—Etoposide—lung cancer	0.000119	0.000808	CcSEcCtD
Montelukast—Gastrointestinal pain—Irinotecan—lung cancer	0.000118	0.0008	CcSEcCtD
Montelukast—Oedema—Paclitaxel—lung cancer	0.000118	0.000797	CcSEcCtD
Montelukast—Anaphylactic shock—Paclitaxel—lung cancer	0.000118	0.000797	CcSEcCtD
Montelukast—Paraesthesia—Cisplatin—lung cancer	0.000118	0.000797	CcSEcCtD
Montelukast—Thrombocytopenia—Etoposide—lung cancer	0.000118	0.000796	CcSEcCtD
Montelukast—Muscle spasms—Docetaxel—lung cancer	0.000118	0.000796	CcSEcCtD
Montelukast—Upper respiratory tract infection—Methotrexate—lung cancer	0.000117	0.000796	CcSEcCtD
Montelukast—Infection—Paclitaxel—lung cancer	0.000117	0.000792	CcSEcCtD
Montelukast—Skin disorder—Etoposide—lung cancer	0.000117	0.00079	CcSEcCtD
Montelukast—Dizziness—Vinorelbine—lung cancer	0.000116	0.000784	CcSEcCtD
Montelukast—Nervous system disorder—Paclitaxel—lung cancer	0.000115	0.000782	CcSEcCtD
Montelukast—Thrombocytopenia—Paclitaxel—lung cancer	0.000115	0.000781	CcSEcCtD
Montelukast—Skin disorder—Paclitaxel—lung cancer	0.000114	0.000775	CcSEcCtD
Montelukast—Abdominal pain—Irinotecan—lung cancer	0.000114	0.000773	CcSEcCtD
Montelukast—Body temperature increased—Irinotecan—lung cancer	0.000114	0.000773	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000114	0.000773	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.000114	0.000773	CcSEcCtD
Montelukast—Pneumonia—Methotrexate—lung cancer	0.000113	0.000768	CcSEcCtD
Montelukast—Nasopharyngitis—Doxorubicin—lung cancer	0.000113	0.000767	CcSEcCtD
Montelukast—Gastrointestinal disorder—Cisplatin—lung cancer	0.000113	0.000766	CcSEcCtD
Montelukast—Infestation NOS—Methotrexate—lung cancer	0.000113	0.000764	CcSEcCtD
Montelukast—Drowsiness—Methotrexate—lung cancer	0.000113	0.000764	CcSEcCtD
Montelukast—Infestation—Methotrexate—lung cancer	0.000113	0.000764	CcSEcCtD
Montelukast—Pain—Cisplatin—lung cancer	0.000112	0.000759	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000112	0.000757	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.000112	0.000757	CcSEcCtD
Montelukast—Vomiting—Vinorelbine—lung cancer	0.000111	0.000754	CcSEcCtD
Montelukast—Body temperature increased—Gemcitabine—lung cancer	0.000111	0.000753	CcSEcCtD
Montelukast—Rash—Vinorelbine—lung cancer	0.00011	0.000747	CcSEcCtD
Montelukast—Dermatitis—Vinorelbine—lung cancer	0.00011	0.000747	CcSEcCtD
Montelukast—Headache—Vinorelbine—lung cancer	0.00011	0.000743	CcSEcCtD
Montelukast—Conjunctivitis—Methotrexate—lung cancer	0.00011	0.000742	CcSEcCtD
Montelukast—Influenza—Doxorubicin—lung cancer	0.000109	0.000742	CcSEcCtD
Montelukast—Asthma—Doxorubicin—lung cancer	0.000109	0.000742	CcSEcCtD
Montelukast—Eosinophilia—Doxorubicin—lung cancer	0.000108	0.000734	CcSEcCtD
Montelukast—Palpitations—Docetaxel—lung cancer	0.000108	0.000732	CcSEcCtD
Montelukast—Paraesthesia—Etoposide—lung cancer	0.000108	0.00073	CcSEcCtD
Montelukast—Pancreatitis—Doxorubicin—lung cancer	0.000107	0.000727	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000107	0.000726	CcSEcCtD
Montelukast—Somnolence—Etoposide—lung cancer	0.000107	0.000723	CcSEcCtD
Montelukast—Cough—Docetaxel—lung cancer	0.000107	0.000723	CcSEcCtD
Montelukast—Hepatobiliary disease—Methotrexate—lung cancer	0.000107	0.000722	CcSEcCtD
Montelukast—Insomnia—Paclitaxel—lung cancer	0.000106	0.000721	CcSEcCtD
Montelukast—Epistaxis—Methotrexate—lung cancer	0.000106	0.00072	CcSEcCtD
Montelukast—Hypersensitivity—Irinotecan—lung cancer	0.000106	0.00072	CcSEcCtD
Montelukast—Convulsion—Docetaxel—lung cancer	0.000106	0.000718	CcSEcCtD
Montelukast—Paraesthesia—Paclitaxel—lung cancer	0.000106	0.000716	CcSEcCtD
Montelukast—Bronchitis—Doxorubicin—lung cancer	0.000105	0.000713	CcSEcCtD
Montelukast—Somnolence—Paclitaxel—lung cancer	0.000105	0.000709	CcSEcCtD
Montelukast—Arthralgia—Docetaxel—lung cancer	0.000104	0.000705	CcSEcCtD
Montelukast—Myalgia—Docetaxel—lung cancer	0.000104	0.000705	CcSEcCtD
Montelukast—Nausea—Vinorelbine—lung cancer	0.000104	0.000704	CcSEcCtD
Montelukast—Gastrointestinal disorder—Etoposide—lung cancer	0.000104	0.000702	CcSEcCtD
Montelukast—Dyspepsia—Paclitaxel—lung cancer	0.000104	0.000702	CcSEcCtD
Montelukast—Body temperature increased—Cisplatin—lung cancer	0.000104	0.000702	CcSEcCtD
Montelukast—Asthenia—Irinotecan—lung cancer	0.000104	0.000701	CcSEcCtD
Montelukast—Fatigue—Etoposide—lung cancer	0.000103	0.000701	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000103	0.0007	CcSEcCtD
Montelukast—Pain—Etoposide—lung cancer	0.000103	0.000695	CcSEcCtD
Montelukast—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000102	0.000689	CcSEcCtD
Montelukast—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000102	0.000688	CcSEcCtD
Montelukast—Fatigue—Paclitaxel—lung cancer	0.000101	0.000687	CcSEcCtD
Montelukast—Hepatitis—Methotrexate—lung cancer	0.000101	0.000686	CcSEcCtD
Montelukast—Asthenia—Gemcitabine—lung cancer	0.000101	0.000683	CcSEcCtD
Montelukast—Pain—Paclitaxel—lung cancer	0.000101	0.000682	CcSEcCtD
Montelukast—Pharyngitis—Methotrexate—lung cancer	0.0001	0.000681	CcSEcCtD
Montelukast—Urinary tract disorder—Methotrexate—lung cancer	9.99e-05	0.000677	CcSEcCtD
Montelukast—Anaphylactic shock—Docetaxel—lung cancer	9.97e-05	0.000676	CcSEcCtD
Montelukast—Oedema—Docetaxel—lung cancer	9.97e-05	0.000676	CcSEcCtD
Montelukast—Pruritus—Gemcitabine—lung cancer	9.94e-05	0.000674	CcSEcCtD
Montelukast—Urethral disorder—Methotrexate—lung cancer	9.92e-05	0.000672	CcSEcCtD
Montelukast—Infection—Docetaxel—lung cancer	9.91e-05	0.000671	CcSEcCtD
Montelukast—Diarrhoea—Irinotecan—lung cancer	9.87e-05	0.000669	CcSEcCtD
Montelukast—Pneumonia—Doxorubicin—lung cancer	9.82e-05	0.000665	CcSEcCtD
Montelukast—Gastrointestinal pain—Etoposide—lung cancer	9.81e-05	0.000665	CcSEcCtD
Montelukast—Nervous system disorder—Docetaxel—lung cancer	9.78e-05	0.000663	CcSEcCtD
Montelukast—Thrombocytopenia—Docetaxel—lung cancer	9.77e-05	0.000662	CcSEcCtD
Montelukast—Infestation NOS—Doxorubicin—lung cancer	9.76e-05	0.000661	CcSEcCtD
Montelukast—Infestation—Doxorubicin—lung cancer	9.76e-05	0.000661	CcSEcCtD
Montelukast—Drowsiness—Doxorubicin—lung cancer	9.76e-05	0.000661	CcSEcCtD
Montelukast—Skin disorder—Docetaxel—lung cancer	9.69e-05	0.000656	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Doxorubicin—lung cancer	9.68e-05	0.000656	CcSEcCtD
Montelukast—Hypersensitivity—Cisplatin—lung cancer	9.65e-05	0.000654	CcSEcCtD
Montelukast—Gastrointestinal pain—Paclitaxel—lung cancer	9.62e-05	0.000652	CcSEcCtD
Montelukast—Diarrhoea—Gemcitabine—lung cancer	9.62e-05	0.000652	CcSEcCtD
Montelukast—Erythema multiforme—Methotrexate—lung cancer	9.57e-05	0.000648	CcSEcCtD
Montelukast—Neuropathy peripheral—Doxorubicin—lung cancer	9.57e-05	0.000648	CcSEcCtD
Montelukast—Dizziness—Irinotecan—lung cancer	9.54e-05	0.000647	CcSEcCtD
Montelukast—Urticaria—Etoposide—lung cancer	9.53e-05	0.000646	CcSEcCtD
Montelukast—Jaundice—Doxorubicin—lung cancer	9.51e-05	0.000645	CcSEcCtD
Montelukast—Abdominal pain—Etoposide—lung cancer	9.49e-05	0.000643	CcSEcCtD
Montelukast—Body temperature increased—Etoposide—lung cancer	9.49e-05	0.000643	CcSEcCtD
Montelukast—Conjunctivitis—Doxorubicin—lung cancer	9.49e-05	0.000643	CcSEcCtD
Montelukast—Asthenia—Cisplatin—lung cancer	9.4e-05	0.000637	CcSEcCtD
Montelukast—Cardiac disorder—Methotrexate—lung cancer	9.39e-05	0.000636	CcSEcCtD
Montelukast—Urticaria—Paclitaxel—lung cancer	9.35e-05	0.000633	CcSEcCtD
Montelukast—Body temperature increased—Paclitaxel—lung cancer	9.3e-05	0.00063	CcSEcCtD
Montelukast—Abdominal pain—Paclitaxel—lung cancer	9.3e-05	0.00063	CcSEcCtD
Montelukast—Hepatobiliary disease—Doxorubicin—lung cancer	9.23e-05	0.000625	CcSEcCtD
Montelukast—Epistaxis—Doxorubicin—lung cancer	9.21e-05	0.000624	CcSEcCtD
Montelukast—Vomiting—Irinotecan—lung cancer	9.17e-05	0.000622	CcSEcCtD
Montelukast—Sinusitis—Doxorubicin—lung cancer	9.16e-05	0.00062	CcSEcCtD
Montelukast—Immune system disorder—Methotrexate—lung cancer	9.14e-05	0.000619	CcSEcCtD
Montelukast—Mediastinal disorder—Methotrexate—lung cancer	9.12e-05	0.000618	CcSEcCtD
Montelukast—Rash—Irinotecan—lung cancer	9.1e-05	0.000616	CcSEcCtD
Montelukast—Dermatitis—Irinotecan—lung cancer	9.09e-05	0.000616	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Docetaxel—lung cancer	9.09e-05	0.000616	CcSEcCtD
Montelukast—Headache—Irinotecan—lung cancer	9.04e-05	0.000613	CcSEcCtD
Montelukast—Insomnia—Docetaxel—lung cancer	9.02e-05	0.000611	CcSEcCtD
Montelukast—Diarrhoea—Cisplatin—lung cancer	8.96e-05	0.000607	CcSEcCtD
Montelukast—Paraesthesia—Docetaxel—lung cancer	8.96e-05	0.000607	CcSEcCtD
Montelukast—Vomiting—Gemcitabine—lung cancer	8.94e-05	0.000606	CcSEcCtD
Montelukast—Somnolence—Docetaxel—lung cancer	8.87e-05	0.000601	CcSEcCtD
Montelukast—Mental disorder—Methotrexate—lung cancer	8.87e-05	0.000601	CcSEcCtD
Montelukast—Rash—Gemcitabine—lung cancer	8.86e-05	0.000601	CcSEcCtD
Montelukast—Dermatitis—Gemcitabine—lung cancer	8.85e-05	0.0006	CcSEcCtD
Montelukast—Hypersensitivity—Etoposide—lung cancer	8.84e-05	0.000599	CcSEcCtD
Montelukast—Headache—Gemcitabine—lung cancer	8.81e-05	0.000597	CcSEcCtD
Montelukast—Rhinitis—Doxorubicin—lung cancer	8.78e-05	0.000595	CcSEcCtD
Montelukast—Dyspepsia—Docetaxel—lung cancer	8.78e-05	0.000595	CcSEcCtD
Montelukast—Hepatitis—Doxorubicin—lung cancer	8.76e-05	0.000594	CcSEcCtD
Montelukast—Hypoaesthesia—Doxorubicin—lung cancer	8.72e-05	0.000591	CcSEcCtD
Montelukast—Pharyngitis—Doxorubicin—lung cancer	8.7e-05	0.000589	CcSEcCtD
Montelukast—Hypersensitivity—Paclitaxel—lung cancer	8.67e-05	0.000587	CcSEcCtD
Montelukast—Urinary tract disorder—Doxorubicin—lung cancer	8.65e-05	0.000586	CcSEcCtD
Montelukast—Gastrointestinal disorder—Docetaxel—lung cancer	8.61e-05	0.000584	CcSEcCtD
Montelukast—Asthenia—Etoposide—lung cancer	8.61e-05	0.000583	CcSEcCtD
Montelukast—Connective tissue disorder—Doxorubicin—lung cancer	8.61e-05	0.000583	CcSEcCtD
Montelukast—Fatigue—Docetaxel—lung cancer	8.6e-05	0.000583	CcSEcCtD
Montelukast—Urethral disorder—Doxorubicin—lung cancer	8.59e-05	0.000582	CcSEcCtD
Montelukast—Nausea—Irinotecan—lung cancer	8.57e-05	0.000581	CcSEcCtD
Montelukast—Pain—Docetaxel—lung cancer	8.53e-05	0.000578	CcSEcCtD
Montelukast—Pruritus—Etoposide—lung cancer	8.49e-05	0.000575	CcSEcCtD
Montelukast—Asthenia—Paclitaxel—lung cancer	8.44e-05	0.000572	CcSEcCtD
Montelukast—Nausea—Gemcitabine—lung cancer	8.35e-05	0.000566	CcSEcCtD
Montelukast—Vomiting—Cisplatin—lung cancer	8.33e-05	0.000564	CcSEcCtD
Montelukast—Pruritus—Paclitaxel—lung cancer	8.33e-05	0.000564	CcSEcCtD
Montelukast—Erythema multiforme—Doxorubicin—lung cancer	8.28e-05	0.000561	CcSEcCtD
Montelukast—Rash—Cisplatin—lung cancer	8.26e-05	0.00056	CcSEcCtD
Montelukast—Dermatitis—Cisplatin—lung cancer	8.25e-05	0.000559	CcSEcCtD
Montelukast—Diarrhoea—Etoposide—lung cancer	8.21e-05	0.000556	CcSEcCtD
Montelukast—Gastrointestinal pain—Docetaxel—lung cancer	8.16e-05	0.000553	CcSEcCtD
Montelukast—Cardiac disorder—Doxorubicin—lung cancer	8.13e-05	0.000551	CcSEcCtD
Montelukast—Diarrhoea—Paclitaxel—lung cancer	8.05e-05	0.000546	CcSEcCtD
Montelukast—Dizziness—Etoposide—lung cancer	7.94e-05	0.000538	CcSEcCtD
Montelukast—Immune system disorder—Doxorubicin—lung cancer	7.91e-05	0.000536	CcSEcCtD
Montelukast—Mediastinal disorder—Doxorubicin—lung cancer	7.9e-05	0.000535	CcSEcCtD
Montelukast—Abdominal pain—Docetaxel—lung cancer	7.88e-05	0.000534	CcSEcCtD
Montelukast—Body temperature increased—Docetaxel—lung cancer	7.88e-05	0.000534	CcSEcCtD
Montelukast—Dizziness—Paclitaxel—lung cancer	7.78e-05	0.000527	CcSEcCtD
Montelukast—Nausea—Cisplatin—lung cancer	7.78e-05	0.000527	CcSEcCtD
Montelukast—Cough—Methotrexate—lung cancer	7.69e-05	0.000521	CcSEcCtD
Montelukast—Mental disorder—Doxorubicin—lung cancer	7.68e-05	0.00052	CcSEcCtD
Montelukast—Convulsion—Methotrexate—lung cancer	7.63e-05	0.000517	CcSEcCtD
Montelukast—Vomiting—Etoposide—lung cancer	7.63e-05	0.000517	CcSEcCtD
Montelukast—Rash—Etoposide—lung cancer	7.57e-05	0.000513	CcSEcCtD
Montelukast—Dermatitis—Etoposide—lung cancer	7.56e-05	0.000512	CcSEcCtD
Montelukast—Headache—Etoposide—lung cancer	7.52e-05	0.000509	CcSEcCtD
Montelukast—Myalgia—Methotrexate—lung cancer	7.5e-05	0.000508	CcSEcCtD
Montelukast—Arthralgia—Methotrexate—lung cancer	7.5e-05	0.000508	CcSEcCtD
Montelukast—Vomiting—Paclitaxel—lung cancer	7.48e-05	0.000507	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	7.45e-05	0.000505	CcSEcCtD
Montelukast—Rash—Paclitaxel—lung cancer	7.42e-05	0.000503	CcSEcCtD
Montelukast—Dermatitis—Paclitaxel—lung cancer	7.41e-05	0.000502	CcSEcCtD
Montelukast—Headache—Paclitaxel—lung cancer	7.37e-05	0.0005	CcSEcCtD
Montelukast—Hypersensitivity—Docetaxel—lung cancer	7.35e-05	0.000498	CcSEcCtD
Montelukast—Muscle spasms—Doxorubicin—lung cancer	7.33e-05	0.000497	CcSEcCtD
Montelukast—Anaphylactic shock—Methotrexate—lung cancer	7.19e-05	0.000487	CcSEcCtD
Montelukast—Asthenia—Docetaxel—lung cancer	7.16e-05	0.000485	CcSEcCtD
Montelukast—Infection—Methotrexate—lung cancer	7.14e-05	0.000484	CcSEcCtD
Montelukast—Nausea—Etoposide—lung cancer	7.13e-05	0.000483	CcSEcCtD
Montelukast—Pruritus—Docetaxel—lung cancer	7.06e-05	0.000478	CcSEcCtD
Montelukast—Nervous system disorder—Methotrexate—lung cancer	7.05e-05	0.000478	CcSEcCtD
Montelukast—Thrombocytopenia—Methotrexate—lung cancer	7.04e-05	0.000477	CcSEcCtD
Montelukast—Agitation—Doxorubicin—lung cancer	7.01e-05	0.000475	CcSEcCtD
Montelukast—Nausea—Paclitaxel—lung cancer	6.99e-05	0.000474	CcSEcCtD
Montelukast—Skin disorder—Methotrexate—lung cancer	6.98e-05	0.000473	CcSEcCtD
Montelukast—Diarrhoea—Docetaxel—lung cancer	6.82e-05	0.000462	CcSEcCtD
Montelukast—Palpitations—Doxorubicin—lung cancer	6.74e-05	0.000457	CcSEcCtD
Montelukast—Cough—Doxorubicin—lung cancer	6.66e-05	0.000451	CcSEcCtD
Montelukast—Convulsion—Doxorubicin—lung cancer	6.61e-05	0.000448	CcSEcCtD
Montelukast—Dizziness—Docetaxel—lung cancer	6.6e-05	0.000447	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Methotrexate—lung cancer	6.55e-05	0.000444	CcSEcCtD
Montelukast—Insomnia—Methotrexate—lung cancer	6.5e-05	0.000441	CcSEcCtD
Montelukast—Arthralgia—Doxorubicin—lung cancer	6.49e-05	0.00044	CcSEcCtD
Montelukast—Myalgia—Doxorubicin—lung cancer	6.49e-05	0.00044	CcSEcCtD
Montelukast—Anxiety—Doxorubicin—lung cancer	6.47e-05	0.000438	CcSEcCtD
Montelukast—Paraesthesia—Methotrexate—lung cancer	6.46e-05	0.000437	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	6.45e-05	0.000437	CcSEcCtD
Montelukast—Somnolence—Methotrexate—lung cancer	6.39e-05	0.000433	CcSEcCtD
Montelukast—Vomiting—Docetaxel—lung cancer	6.34e-05	0.00043	CcSEcCtD
Montelukast—Dyspepsia—Methotrexate—lung cancer	6.33e-05	0.000429	CcSEcCtD
Montelukast—Rash—Docetaxel—lung cancer	6.29e-05	0.000426	CcSEcCtD
Montelukast—Dermatitis—Docetaxel—lung cancer	6.28e-05	0.000426	CcSEcCtD
Montelukast—Headache—Docetaxel—lung cancer	6.25e-05	0.000423	CcSEcCtD
Montelukast—Oedema—Doxorubicin—lung cancer	6.23e-05	0.000422	CcSEcCtD
Montelukast—Anaphylactic shock—Doxorubicin—lung cancer	6.23e-05	0.000422	CcSEcCtD
Montelukast—Gastrointestinal disorder—Methotrexate—lung cancer	6.21e-05	0.000421	CcSEcCtD
Montelukast—Fatigue—Methotrexate—lung cancer	6.2e-05	0.00042	CcSEcCtD
Montelukast—Infection—Doxorubicin—lung cancer	6.18e-05	0.000419	CcSEcCtD
Montelukast—Pain—Methotrexate—lung cancer	6.15e-05	0.000417	CcSEcCtD
Montelukast—Nervous system disorder—Doxorubicin—lung cancer	6.1e-05	0.000414	CcSEcCtD
Montelukast—Thrombocytopenia—Doxorubicin—lung cancer	6.09e-05	0.000413	CcSEcCtD
Montelukast—Skin disorder—Doxorubicin—lung cancer	6.05e-05	0.00041	CcSEcCtD
Montelukast—Nausea—Docetaxel—lung cancer	5.92e-05	0.000401	CcSEcCtD
Montelukast—Gastrointestinal pain—Methotrexate—lung cancer	5.88e-05	0.000398	CcSEcCtD
Montelukast—Urticaria—Methotrexate—lung cancer	5.71e-05	0.000387	CcSEcCtD
Montelukast—Abdominal pain—Methotrexate—lung cancer	5.68e-05	0.000385	CcSEcCtD
Montelukast—Body temperature increased—Methotrexate—lung cancer	5.68e-05	0.000385	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Doxorubicin—lung cancer	5.67e-05	0.000384	CcSEcCtD
Montelukast—Insomnia—Doxorubicin—lung cancer	5.63e-05	0.000382	CcSEcCtD
Montelukast—Paraesthesia—Doxorubicin—lung cancer	5.59e-05	0.000379	CcSEcCtD
Montelukast—Somnolence—Doxorubicin—lung cancer	5.53e-05	0.000375	CcSEcCtD
Montelukast—Dyspepsia—Doxorubicin—lung cancer	5.48e-05	0.000371	CcSEcCtD
Montelukast—Gastrointestinal disorder—Doxorubicin—lung cancer	5.37e-05	0.000364	CcSEcCtD
Montelukast—Fatigue—Doxorubicin—lung cancer	5.37e-05	0.000364	CcSEcCtD
Montelukast—Pain—Doxorubicin—lung cancer	5.32e-05	0.000361	CcSEcCtD
Montelukast—Hypersensitivity—Methotrexate—lung cancer	5.3e-05	0.000359	CcSEcCtD
Montelukast—Asthenia—Methotrexate—lung cancer	5.16e-05	0.00035	CcSEcCtD
Montelukast—Gastrointestinal pain—Doxorubicin—lung cancer	5.09e-05	0.000345	CcSEcCtD
Montelukast—Pruritus—Methotrexate—lung cancer	5.09e-05	0.000345	CcSEcCtD
Montelukast—Urticaria—Doxorubicin—lung cancer	4.95e-05	0.000335	CcSEcCtD
Montelukast—Abdominal pain—Doxorubicin—lung cancer	4.92e-05	0.000333	CcSEcCtD
Montelukast—Body temperature increased—Doxorubicin—lung cancer	4.92e-05	0.000333	CcSEcCtD
Montelukast—Diarrhoea—Methotrexate—lung cancer	4.92e-05	0.000333	CcSEcCtD
Montelukast—Dizziness—Methotrexate—lung cancer	4.75e-05	0.000322	CcSEcCtD
Montelukast—Hypersensitivity—Doxorubicin—lung cancer	4.59e-05	0.000311	CcSEcCtD
Montelukast—Vomiting—Methotrexate—lung cancer	4.57e-05	0.00031	CcSEcCtD
Montelukast—Rash—Methotrexate—lung cancer	4.53e-05	0.000307	CcSEcCtD
Montelukast—Dermatitis—Methotrexate—lung cancer	4.53e-05	0.000307	CcSEcCtD
Montelukast—Headache—Methotrexate—lung cancer	4.5e-05	0.000305	CcSEcCtD
Montelukast—Asthenia—Doxorubicin—lung cancer	4.47e-05	0.000303	CcSEcCtD
Montelukast—Pruritus—Doxorubicin—lung cancer	4.4e-05	0.000298	CcSEcCtD
Montelukast—Nausea—Methotrexate—lung cancer	4.27e-05	0.000289	CcSEcCtD
Montelukast—Diarrhoea—Doxorubicin—lung cancer	4.26e-05	0.000289	CcSEcCtD
Montelukast—Dizziness—Doxorubicin—lung cancer	4.12e-05	0.000279	CcSEcCtD
Montelukast—Vomiting—Doxorubicin—lung cancer	3.96e-05	0.000268	CcSEcCtD
Montelukast—Rash—Doxorubicin—lung cancer	3.92e-05	0.000266	CcSEcCtD
Montelukast—Dermatitis—Doxorubicin—lung cancer	3.92e-05	0.000266	CcSEcCtD
Montelukast—Headache—Doxorubicin—lung cancer	3.9e-05	0.000264	CcSEcCtD
Montelukast—Nausea—Doxorubicin—lung cancer	3.7e-05	0.000251	CcSEcCtD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.47e-05	0.000177	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—B4GALT5—lung cancer	1.47e-05	0.000176	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ATP5H—lung cancer	1.46e-05	0.000175	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—ERBB2—lung cancer	1.46e-05	0.000175	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—POMC—lung cancer	1.45e-05	0.000175	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MTOR—lung cancer	1.44e-05	0.000173	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PIK3CB—lung cancer	1.44e-05	0.000173	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTA4—lung cancer	1.43e-05	0.000172	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP2A7—lung cancer	1.43e-05	0.000171	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ENO1—lung cancer	1.41e-05	0.00017	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.4e-05	0.000168	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SDC4—lung cancer	1.4e-05	0.000168	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTA2—lung cancer	1.39e-05	0.000167	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CXCL8—lung cancer	1.38e-05	0.000166	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—HRAS—lung cancer	1.37e-05	0.000165	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTA1—lung cancer	1.34e-05	0.000161	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CYP2E1—lung cancer	1.34e-05	0.000161	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—AKT1—lung cancer	1.33e-05	0.00016	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PIK3CB—lung cancer	1.33e-05	0.00016	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ABCC3—lung cancer	1.33e-05	0.00016	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—NQO1—lung cancer	1.32e-05	0.000159	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CASP3—lung cancer	1.32e-05	0.000159	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PTGS2—lung cancer	1.32e-05	0.000159	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IL2—lung cancer	1.32e-05	0.000159	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—IL6—lung cancer	1.31e-05	0.000158	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PLBD1—lung cancer	1.3e-05	0.000156	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.3e-05	0.000156	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CCND1—lung cancer	1.29e-05	0.000155	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—AKR1C1—lung cancer	1.29e-05	0.000155	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.28e-05	0.000154	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—JUN—lung cancer	1.28e-05	0.000154	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—RRM1—lung cancer	1.27e-05	0.000153	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTA3—lung cancer	1.27e-05	0.000153	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CYP2E1—lung cancer	1.27e-05	0.000152	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—NQO1—lung cancer	1.25e-05	0.000151	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MMP9—lung cancer	1.25e-05	0.00015	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—UGT1A1—lung cancer	1.25e-05	0.00015	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CDKN1A—lung cancer	1.24e-05	0.00015	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PTEN—lung cancer	1.24e-05	0.000149	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—AKT1—lung cancer	1.21e-05	0.000146	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GNG11—lung cancer	1.2e-05	0.000145	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.2e-05	0.000144	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—B4GALT5—lung cancer	1.19e-05	0.000144	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—STK11—lung cancer	1.19e-05	0.000143	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HSD17B10—lung cancer	1.19e-05	0.000143	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—EP300—lung cancer	1.18e-05	0.000142	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTA4—lung cancer	1.16e-05	0.00014	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—SRC—lung cancer	1.15e-05	0.000138	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PTEN—lung cancer	1.15e-05	0.000138	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ALDOA—lung cancer	1.15e-05	0.000138	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.14e-05	0.000137	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTA2—lung cancer	1.13e-05	0.000136	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—STK11—lung cancer	1.13e-05	0.000136	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—VEGFA—lung cancer	1.12e-05	0.000135	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.12e-05	0.000135	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—NCOA3—lung cancer	1.11e-05	0.000134	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—STAT3—lung cancer	1.11e-05	0.000133	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NRAS—lung cancer	1.11e-05	0.000133	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CKB—lung cancer	1.11e-05	0.000133	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GSTP1—lung cancer	1.1e-05	0.000133	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—EP300—lung cancer	1.1e-05	0.000132	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.09e-05	0.000131	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTA1—lung cancer	1.09e-05	0.000131	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ABCG2—lung cancer	1.08e-05	0.00013	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ADCY1—lung cancer	1.08e-05	0.00013	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ABCC3—lung cancer	1.08e-05	0.00013	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CAT—lung cancer	1.07e-05	0.000129	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.07e-05	0.000128	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—HPGDS—lung cancer	1.06e-05	0.000128	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ENO2—lung cancer	1.06e-05	0.000128	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MAPK3—lung cancer	1.06e-05	0.000128	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PPP2R1B—lung cancer	1.05e-05	0.000127	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—AKR1C1—lung cancer	1.05e-05	0.000126	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ABCB1—lung cancer	1.05e-05	0.000126	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GSTP1—lung cancer	1.04e-05	0.000126	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.04e-05	0.000125	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTM2—lung cancer	1.04e-05	0.000125	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CNDP2—lung cancer	1.04e-05	0.000125	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MYC—lung cancer	1.03e-05	0.000124	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTT1—lung cancer	1.03e-05	0.000124	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—TYMS—lung cancer	1.03e-05	0.000123	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP2A6—lung cancer	1.02e-05	0.000122	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GCLC—lung cancer	1.02e-05	0.000122	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CAT—lung cancer	1.02e-05	0.000122	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—UGT1A1—lung cancer	1.02e-05	0.000122	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GSTM1—lung cancer	1.02e-05	0.000122	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.01e-05	0.000122	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—MTMR3—lung cancer	1.01e-05	0.000122	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—EGFR—lung cancer	1.01e-05	0.000121	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ABCB1—lung cancer	9.89e-06	0.000119	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PGAM1—lung cancer	9.86e-06	0.000118	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GNG11—lung cancer	9.8e-06	0.000118	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	9.75e-06	0.000117	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—TYMS—lung cancer	9.71e-06	0.000117	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ENO1—lung cancer	9.65e-06	0.000116	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CYP1A1—lung cancer	9.62e-06	0.000116	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	9.61e-06	0.000116	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GSTM1—lung cancer	9.6e-06	0.000115	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ERCC2—lung cancer	9.54e-06	0.000115	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—KRAS—lung cancer	9.53e-06	0.000115	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—ALB—lung cancer	9.49e-06	0.000114	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP2A7—lung cancer	9.4e-06	0.000113	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ALDOA—lung cancer	9.33e-06	0.000112	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SDC4—lung cancer	9.2e-06	0.000111	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CYP1A1—lung cancer	9.1e-06	0.000109	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—NCOA3—lung cancer	9.05e-06	0.000109	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ERCC2—lung cancer	9.02e-06	0.000108	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	8.9e-06	0.000107	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ADCY1—lung cancer	8.81e-06	0.000106	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ABCG2—lung cancer	8.81e-06	0.000106	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PIK3CA—lung cancer	8.76e-06	0.000105	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP2E1—lung cancer	8.65e-06	0.000104	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—HPGDS—lung cancer	8.64e-06	0.000104	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ENO2—lung cancer	8.64e-06	0.000104	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PPP2R1B—lung cancer	8.58e-06	0.000103	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—NQO1—lung cancer	8.55e-06	0.000103	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TP53—lung cancer	8.47e-06	0.000102	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	8.47e-06	0.000102	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—RRM1—lung cancer	8.38e-06	0.000101	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTA3—lung cancer	8.38e-06	0.000101	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTT1—lung cancer	8.38e-06	0.000101	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	8.38e-06	0.000101	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	8.3e-06	9.98e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP2A6—lung cancer	8.28e-06	9.95e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GCLC—lung cancer	8.28e-06	9.95e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—APOA1—lung cancer	8.26e-06	9.92e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	8.25e-06	9.91e-05	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PIK3CA—lung cancer	8.12e-06	9.76e-05	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—HRAS—lung cancer	8.1e-06	9.74e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.91e-06	9.5e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—B4GALT5—lung cancer	7.88e-06	9.47e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ENO1—lung cancer	7.85e-06	9.43e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	7.82e-06	9.4e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—APOA1—lung cancer	7.81e-06	9.38e-05	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IL6—lung cancer	7.76e-06	9.32e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	7.72e-06	9.28e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—STK11—lung cancer	7.71e-06	9.27e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTA4—lung cancer	7.66e-06	9.21e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CG—lung cancer	7.54e-06	9.06e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTA2—lung cancer	7.47e-06	8.98e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	7.24e-06	8.7e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTA1—lung cancer	7.21e-06	8.66e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—POMC—lung cancer	7.17e-06	8.62e-05	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—AKT1—lung cancer	7.16e-06	8.6e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTP1—lung cancer	7.14e-06	8.58e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CG—lung cancer	7.13e-06	8.57e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ABCC3—lung cancer	7.13e-06	8.56e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP2E1—lung cancer	7.04e-06	8.46e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CREBBP—lung cancer	6.99e-06	8.4e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—NQO1—lung cancer	6.96e-06	8.37e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CAT—lung cancer	6.94e-06	8.34e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.9e-06	8.3e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—AKR1C1—lung cancer	6.9e-06	8.29e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.82e-06	8.19e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—POMC—lung cancer	6.78e-06	8.15e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.76e-06	8.12e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ABCB1—lung cancer	6.75e-06	8.12e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—UGT1A1—lung cancer	6.7e-06	8.05e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—TYMS—lung cancer	6.63e-06	7.97e-05	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—AKT1—lung cancer	6.63e-06	7.97e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CD—lung cancer	6.63e-06	7.96e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CREBBP—lung cancer	6.61e-06	7.94e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTM1—lung cancer	6.56e-06	7.88e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ALB—lung cancer	6.54e-06	7.86e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GNG11—lung cancer	6.46e-06	7.76e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—STK11—lung cancer	6.28e-06	7.54e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CD—lung cancer	6.27e-06	7.53e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP1A1—lung cancer	6.22e-06	7.47e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ALB—lung cancer	6.19e-06	7.43e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ERCC2—lung cancer	6.16e-06	7.41e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ALDOA—lung cancer	6.15e-06	7.39e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—NCOA3—lung cancer	5.97e-06	7.18e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.89e-06	7.08e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ABCG2—lung cancer	5.81e-06	6.98e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ADCY1—lung cancer	5.81e-06	6.98e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTP1—lung cancer	5.81e-06	6.98e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CB—lung cancer	5.78e-06	6.94e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PTGS2—lung cancer	5.72e-06	6.88e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ENO2—lung cancer	5.7e-06	6.85e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HPGDS—lung cancer	5.7e-06	6.85e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PPP2R1B—lung cancer	5.66e-06	6.8e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CAT—lung cancer	5.65e-06	6.79e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.62e-06	6.75e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTT1—lung cancer	5.53e-06	6.64e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ABCB1—lung cancer	5.5e-06	6.61e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GCLC—lung cancer	5.46e-06	6.56e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP2A6—lung cancer	5.46e-06	6.56e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CB—lung cancer	5.46e-06	6.56e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PTGS2—lung cancer	5.41e-06	6.5e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—TYMS—lung cancer	5.4e-06	6.49e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTM1—lung cancer	5.34e-06	6.41e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—APOA1—lung cancer	5.33e-06	6.41e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ENO1—lung cancer	5.18e-06	6.22e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.11e-06	6.14e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP1A1—lung cancer	5.06e-06	6.08e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ERCC2—lung cancer	5.02e-06	6.03e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PTEN—lung cancer	4.99e-06	6e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CG—lung cancer	4.87e-06	5.85e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—EP300—lung cancer	4.76e-06	5.72e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PTEN—lung cancer	4.72e-06	5.67e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP2E1—lung cancer	4.64e-06	5.58e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—POMC—lung cancer	4.63e-06	5.57e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—NQO1—lung cancer	4.59e-06	5.52e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CREBBP—lung cancer	4.51e-06	5.43e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—EP300—lung cancer	4.5e-06	5.41e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—APOA1—lung cancer	4.34e-06	5.22e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CD—lung cancer	4.28e-06	5.14e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ALB—lung cancer	4.23e-06	5.08e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.16e-06	4.99e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—STK11—lung cancer	4.14e-06	4.97e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CG—lung cancer	3.96e-06	4.76e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTP1—lung cancer	3.83e-06	4.6e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—POMC—lung cancer	3.77e-06	4.53e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CB—lung cancer	3.73e-06	4.48e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CAT—lung cancer	3.73e-06	4.48e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PTGS2—lung cancer	3.7e-06	4.44e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CREBBP—lung cancer	3.67e-06	4.42e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ABCB1—lung cancer	3.63e-06	4.36e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—TYMS—lung cancer	3.56e-06	4.28e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CA—lung cancer	3.52e-06	4.23e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTM1—lung cancer	3.52e-06	4.23e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CD—lung cancer	3.48e-06	4.19e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ALB—lung cancer	3.44e-06	4.13e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP1A1—lung cancer	3.34e-06	4.01e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CA—lung cancer	3.33e-06	4e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ERCC2—lung cancer	3.31e-06	3.98e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PTEN—lung cancer	3.22e-06	3.87e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—EP300—lung cancer	3.07e-06	3.69e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CB—lung cancer	3.04e-06	3.65e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PTGS2—lung cancer	3.01e-06	3.62e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—AKT1—lung cancer	2.88e-06	3.46e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—APOA1—lung cancer	2.86e-06	3.44e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—AKT1—lung cancer	2.72e-06	3.27e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PTEN—lung cancer	2.62e-06	3.15e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CG—lung cancer	2.61e-06	3.14e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—EP300—lung cancer	2.5e-06	3.01e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—POMC—lung cancer	2.49e-06	2.99e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CREBBP—lung cancer	2.42e-06	2.91e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CD—lung cancer	2.3e-06	2.76e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CA—lung cancer	2.27e-06	2.73e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ALB—lung cancer	2.27e-06	2.73e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CB—lung cancer	2e-06	2.41e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PTGS2—lung cancer	1.98e-06	2.38e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—AKT1—lung cancer	1.86e-06	2.23e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CA—lung cancer	1.85e-06	2.22e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PTEN—lung cancer	1.73e-06	2.08e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—EP300—lung cancer	1.65e-06	1.98e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—AKT1—lung cancer	1.51e-06	1.82e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CA—lung cancer	1.22e-06	1.47e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—AKT1—lung cancer	9.97e-07	1.2e-05	CbGpPWpGaD
